Moderator: ofonorow
8 1 gm ascorbic acid pills very often
Rife machine treatment two days ago was to create a massive Cold Virus?
Owen:
This sounds interesting! Except to you! I know GONE is what your looking for!
First some questions??
Did they do a TSH,t3,t4,t8 test on you? (Blood draw test) if they did were the results abnormal at all?
Antibiotic Therapy
Efforts to demonstrate the effectiveness of tetracycline therapy were initiated and first reported over 40 years ago by Thomas McPherson Brown, M.D. Two weeks after Brown's death in 1989, NIH requested grant applications for the controlled clinical trials of tetracycline therapy for rheumatoid arthritis which he had been seeking. The preliminary results of the clinical trials, known now as MIRA or Minocycline in Rheumatoid Arthritis, were promising and the NIH requested grant applications for studies of mycoplasma and other infectious agents as causes for rheumatoid diseases in 1993, and a pilot study for intravenous antibiotics for rheumatoid arthritis in 1994.
The result of the MIRA clinical trial stated, "Patients who suffer from mild to moderate RA now have the choice of another therapeutic agent. Not only did the antibiotic significantly reduce symptoms, but side effects were minimal and less severe than observed for most other common rheumatoid treatments".
If I were to take a guess I would say Fungal with a lean towards Aspergillus but that's for your providers to figure out.
Aspergillus Osteomyelitis and Septic Arthritis
Key recommendations.Combined medical and surgical intervention is recommended, where feasible, for management of Aspergillus osteomyelitis and arthritis (B-III). Diagnostic imaging with CT and/or MRI is essential for staging disease and for providing a guide for orthopedic and/or neurosurgical intervention. Although there is currently limited experience with voriconazole for treatment of Aspergillus osteomyelitis, voriconazole appears to be effective for this indication (B-II). Historically, AMB has been used and would be appropriate therapy in this context (B-II). Treatment for a minimum of 6–8 weeks is warranted in nonimmunocompromised patients. For immunocompromised patients, consideration for long-term suppressive therapy or treatment throughout the duration of immunosuppression is appropriate.
Users browsing this forum: No registered users and 26 guests